Radiofrequency ablation for hepatic metastasis from gastric adenocarcinoma

Yonsei Medical Journal

Volumn 49, Issue 6, 2008, Pages 1046-1051

  An, Ji Yeong ^a   Kim, Je Yeon ^a   Choi, Min Gew ^a   Noh, Jae Hyung ^a   Choi, Dongil ^a   Sohn, Tae Sung ^a   Kim, Sung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Liver; Metastasis; Neoplasms; Radiofrequency ablation; Stomach

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; GASTRECTOMY BILLROTH I; GASTRECTOMY BILLROTH II; GASTROINTESTINAL ENDOSCOPY; HUMAN; LIVER BIOPSY; LIVER METASTASIS; LIVER RESECTION; MALE; MELENA; MULTIPLE CYCLE TREATMENT; RADIOFREQUENCY ABLATION; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; TREATMENT DURATION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; ULTRASOUND;

ADENOCARCINOMA; ADULT; AGED; CATHETER ABLATION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149456673     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.6.1046     Document Type: Article

References (22)

1. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg 2001;181: 279-83.
2. Saiura A, Umekita N, Inoue S, Maeshiro T, Miyamoto S, Matsui Y, et al. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 2002;49:1062-5.
3. Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, et al. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol 2005;11: 6395-401.
4. De Baere T, Elias D, Ducreux M, Dromain C, Kuach V, Gamal El Din M, et al. [Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience]. Gastroenterol Clin Biol 1999;23:1128-33.
5. Iannitti DA, Dupuy DE, Mayo-Smith WW, Murphy B. Hepatic radiofrequency ablation. Arch Surg 2002;137: 422-6; discussion 427.
6. Carditello A, Scisca C, Stilo F, Parisi A, Basile M. The possible role of radiofrequency as complementary treatment of locally advanced gastric cancer. Ann Ital Chir 2005;76:39-41.
7. Yamakado K, Nakatsuka A, Takaki H, Mori Y, Tonouchi H, Kusunoki M, et al. Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer. J Vasc Interv Radiol 2005;16:1747-51.
8. Sobin LH, Wittekind CH, editors. TNM: classification of malignant tumors. 6th ed. New York, NY: Wiley-Liss; 2002. p.65-8.
9. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 2002;235:86-91.
10. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 2003;133:507-11.
11. Koga S, Kawaguchi H, Kishimoto H, Tanaka K, Miyano Y, Kimura O, et al. Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasis. Am J Surg 1980;140:356-9.
12. Adam YG, Efron G. Trends and controversies in the management of carcinoma of the stomach. Surg Gynecol Obstet 1989;169:371-85.
13. Ercolani G, Grazi GL, Ravaioli M, Ramacciato G, Cescon M, Varotti G, et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol 2005;12:459-66.
14. Taniguchi H, Takahashi T, Sawai K, Yamaguchi T, Hagiwara A, Kitamura K, et al. Comparison in survival between hepatic metastases of gastric and colorectal cancers. Hepatogastroenterology 1997;44:897-900.
15. Zacherl J, Zacherl M, Scheuba C, Steininger R, Wenzl E, Mühlbacher F, et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 2002;6:682-9.
16. Morise Z, Yamafuji K, Takahashi T, Asami A, Takeshima K, Hayashi N, et al. Successful treatment of recurrent liver metastases from gastric cancer by repeated hepatic resections: report of a case. Surg Today 2000;30:1041-5.
17. Roh HR, Suh KS, Lee HJ, Yang HK, Choe KJ, Lee KU. Outcome of hepatic resection for metastatic gastric cancer. Am Surg 2005;71:95-9.
18. Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221: 159-66.
19. Gannon CJ, Curley SA. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors. Semin Radiat Oncol 2005;15: 265-72.
20. de Baere T, Elias D, Dromain C, Din MG, Kuoch V, Ducreux M, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000;175:1619-25.
21. Kosaka T, Imaizumi H, Kamei K, Usami K, Nakano Y, Ueno K, et al. [A case of gastric cancer patient with liver metastasis treated by radiofrequency ablation therapy combined with intra-arterial chemotherapy]. Gan To Kagaku Ryoho 2004;31:1737-9.
22. Shirabe K, Shimada M, Matsumata T, Higashi H, Yakeishi Y, Wakiyama S, et al. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology 2003; 50:1560-3.